Trevena Inc (TRVN) Wednesday reported fourth-quarter losses that were wider than analysts’ estimates, sending its shares down 5.4% during pre-market trading. Helped
Earnings: Trevena slips on wider-than-expected Q4 loss
Categories
Health Care
Cara Therapeutics stock surges after reporting Q4 earnings results
Cara Therapuetics (CARA) reports a loss of $20.7 million or $0.52 per share on revenue of $5.5 million for the fourth quarter
Avid Bioservices stock jumps after Q3 loss narrows on higher revenues
Avid Bioservices (CDMO) reported a narrower net loss for the third quarter of 2019, aided by a sharp increase in revenues and
Viking Therapeutics earnings preview: All eyes on NASH
Viking Therapeutics (VKTX) is scheduled to report fourth-quarter 2018 financial results on March 13, Wednesday, after the regular trading hours. The market
Earnings Preview Q4: Cara Therapeutics’ success in 2019 will depend on Korsuva trial outcomes
Cara Therapeutics (CARA) is scheduled to report its fourth quarter and full-year 2018 financial results on Tuesday, March 12, after the regular
Tilray rides on successful cannabis harvest in Europe
Tilray’s (TLRY) stock made strong gains early Wednesday after the Canadian marijuana giant said its European arm had a very successful cannabis
Aurora Cannabis dethrones Canopy Growth as Cowen’s top pot stock
Research firm Cowen on Tuesday named Aurora Cannabis (ACB) its top stock pick for the marijuana industry, replacing Canopy Growth (CGC). The
La Jolla Pharma stock declines after reporting Q4 earnings results
La Jolla Pharmaceutical Company (LJPC) reported its Q4 and full-year 2018 results after the market closed today. The company reported a loss
Biogen buys Nightstar, eyeing a bigger pie in ophthalmic gene therapy
Continuing the efforts to diversify into new areas of drug development, Biogen (BIIB) this week clinched an important deal that would expedite
Portola Pharmaceuticals rises on strong Q4 earnings
Shares of Portola Pharmaceuticals (PTLA) gained 5.6% during pre-market trading on Friday, after the company posted a loss of $1.04 per share,
Earnings: Dentsply Sirona Q4 profit beats despite revenue drop; stock jumps
Dentsply Sirona (XRAY), a provider of dental products and technology, reported a decline in earnings and revenues for the fourth quarter of
Celgene stock takes a dive after major Bristol-Myers stakeholder opposes merger deal
It's was a wild day for big pharma after Celgene Corp (CELG) slid at least 8% on early Thursday trade after one
Trending stocks: Tandem Diabetes, Weight Watchers, MercadoLibre and more
TOP GAINERS Tandem Diabetes Care (TNDM) on Tuesday said its COO John Sheridan will take over as the CEO of the company,
Amarin’s stock gains after Q4 revenues beat expectations
Amarin Corporation (AMRN) surpassed analysts’ expectations on revenues for the fourth quarter of 2018 while net loss came in higher-than-expected. Shares rose
Mylan stock tanks on Q4 earnings miss; issues full-year guidance
Shares of Mylan NV (MYL) fell sharply Tuesday after the specialty pharmaceuticals company reported a decline in its fourth-quarter earnings which also
GW Pharma stock rises after reporting earnings results for the quarter ended Dec. 31, 2018
As GW Pharmaceuticals (GWPH) moved its fiscal year beginning to January 1, 2019, the company reported financial results for the quarter ended 31
Aurora Cannabis to start production in Portugal
In line with its strategy to achieve an early-mover advantage in as many new markets as possible, Canadian marijuana giant Aurora Cannabis
Zynerba Pharmaceuticals stock soars on receiving US patent for its CBD gel to treat Fragile X syndrome
Cannabinoid therapeutics developer Zynerba Pharmaceuticals (ZYNE) received US patent named "Treatment of Fragile X Syndrome with Cannabidiol”. Shares of Zynerba soared 15% in
Mallinckrodt’s stock soars 12% on Q4 results beat
Mallinckrodt plc (MNK) topped market expectations on revenue and earnings for the fourth quarter of 2018, sending the shares soaring 12.9% in
Immunomedics tanks after CEO Michael Pehl’s exit and ‘transition period’ results
Immunomedics (IMMU) plunged about 10% in the extended trading hours after the company announced about CEO Michael Pehl's exit from the role
Earnings preview: Amarin likely to deliver strong Q4 results
Amarin Corporation (AMRN) is scheduled to report earnings results for the fourth quarter of 2018 on Wednesday, February 27, before the market